Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Virology|July 21, 2004
Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cellsNina Mossadegh, Lutz Gissmann, Martin Müller, et al.
Cancer Research|December 24, 2009
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patternsMarkus Schmitt, Véronique Dalstein, Tim Waterboer, et al.
Transgenic Research|August 19, 2007
Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic patternKerstin Leykauf, Kirsten Kabsch, Nikolaus Gassler, et al.
Molecular and Cellular Probes|June 14, 2011
The HPV16 transcriptome in cervical lesions of different gradesMarkus Schmitt, Véronique Dalstein, Tim Waterboer, et al.
Plos One|November 26, 2014
Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling)Fahad N Almajhdi, Tilo Senger, Haitham M Amer, et al.
The Journal of General Virology|December 11, 2012
Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesisDaniele Viarisio, Karin Müller Decker, Birgit Aengeneyndt, et al.
Antiviral Therapy|December 25, 2009
Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectorsKaren Nieto, Andrea Kern, Barbara Leuchs, et al.
International Journal of Cancer|April 10, 2009
Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvantsPeter Ohlschläger, Michael Quetting, Gerardo Alvarez, et al.
Virology|October 1, 2019
Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposureDaniele Viarisio, Alexis Robitaille, Karin Müller-Decker, et al.
Human Gene Therapy|March 10, 2012
Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaquesKaren Nieto, Christiane Stahl-Hennig, Barbara Leuchs, et al.
Pageof 7